RNAC
Cartesian Therapeutics, Inc. SEC filings
Every EDGAR filing for Cartesian Therapeutics, Inc. (RNAC), newest first, with AI summaries and stories.
- Ticker
- RNAC
- CIK
- 1453687
- Sector
- Biotech and pharma
- Latest filing
- Sep 29
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINESCHEDULE 13GCartesian Therapeutics, Inc.RNACLIVE Ownership stake disclosure by BARCLAYS PLC
BARCLAYS PLC, filed by
NOTABLE10-QCartesian Therapeutics, Inc.RNACLIVE ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINESCHEDULE 13G/ACartesian Therapeutics, Inc.RNACLIVE Ownership stake disclosure by JPMORGAN CHASE & CO (amended)
JPMORGAN CHASE & CO, filed by
ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINE144Cartesian Therapeutics, Inc.RNACLIVE Milos Miljkovic, planned sale of RNAC shares
Milos Miljkovic, reporting
ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINE144Cartesian Therapeutics, Inc.RNACLIVE Milos Miljkovic, planned sale of RNAC shares
Milos Miljkovic, reporting
ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINESCHEDULE 13G/ACartesian Therapeutics, Inc.RNACLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINES-8Cartesian Therapeutics, Inc.RNACLIVE NOTABLE10-QCartesian Therapeutics, Inc.RNACLIVE ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINEDEF 14ACartesian Therapeutics, Inc.RNACLIVE ROUTINEDEFA14ACartesian Therapeutics, Inc.RNACLIVE ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE 2 insider filings
Seven One Eight Three Four Irrevocable Trust, insider filing for RNAC
Show all 2
- 4Insider filing for RNAC
- 4Insider filing for RNAC
Seven One Eight Three Four Irrevocable Trust, reporting · Elizabeth Hoge, reporting
NOTABLESCHEDULE 13D/ACartesian Therapeutics, Inc.RNACLIVE Ownership stake disclosure by Murat Kalayoglu (amended)
Murat Kalayoglu, filed by
ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE Michael Singer, insider filing for RNAC
Michael Singer, reporting
ROUTINESCHEDULE 13GCartesian Therapeutics, Inc.RNACLIVE Ownership stake disclosure by Squarepoint Ops LLC
Squarepoint Ops LLC, filed by
NOTABLE10-KCartesian Therapeutics, Inc.RNACLIVE ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINESCHEDULE 13G/ACartesian Therapeutics, Inc.RNACLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE144Cartesian Therapeutics, Inc.RNACLIVE Christopher M Jewell, planned sale of RNAC shares
Christopher M Jewell, reporting
ROUTINE144Cartesian Therapeutics, Inc.RNACLIVE Christopher M Jewell, planned sale of RNAC shares
Christopher M Jewell, reporting
ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE 3 insider filings
Carsten Brunn, insider filing for RNAC
Show all 3
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
Carsten Brunn, reporting
ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE 12 insider filings
Nishan M DeSilva, insider filing for RNAC
Show all 12
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
- 4Insider filing for RNAC
Nishan M DeSilva, reporting
ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE Emily English, insider filing for RNAC
Emily English, reporting
ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE 2 insider filings
Adrian Ion Bot, insider filing for RNAC
Show all 2
- 4Insider filing for RNAC
- 3New insider at RNAC
Adrian Ion Bot, reporting
ROUTINE8-KCartesian Therapeutics, Inc.RNACLIVE ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE Timothy C Barabe, insider filing for RNAC
Timothy C Barabe, reporting
ROUTINE4Cartesian Therapeutics, Inc.RNACLIVE Emily English, insider filing for RNAC
Emily English, reporting
ROUTINE144Cartesian Therapeutics, Inc.RNACLIVE Cartesian Therapeutics, Inc. filed Form 144 (Proposed Securities Sale)
- Notice of proposed sale of securities
- Required for restricted stock sales
Christopher M Jewell, reporting